Johnson & Johnson (JNJ.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap504.06B
Enterprise Value532.28B
P/E Ratio26.68
PEG Ratio-6.05
Price/Sales Ratio5.78
Price/Book Ratio6.97
Enterprise/Revenue6.12
Enterprise/EBITDA17.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.22
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.26

Income Statement

Revenue94.2B
Revenue/Share39.41
Gross Profit68.56B
EBITDA41.06B
Net Income26.81B
Diluted EPS11.03

Balance Sheet

Total Cash22.05B
Total Cash/Share9.02
Total Debt54.99B
Total Debt/Equity0.68
Current Ratio1.03
Book Value Per Share33.2

Price History

52-Week Change54.56
52-Week High214.85
52-Week Low129.12
Moving Average 50 Days197.22
Moving Average 200 Days186.34

Statistics

Average Volume2,054
Shares Outstanding2.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5.24
Trailing Annual Dividend Yield2.27
Payout Ratio0.6
Last Split FactorN/A
Last Split DateN/A
AD